Dr. Alison Yarnall completed her PhD in 2013 at Newcastle University looking at biomarkers of cognitive impairment in Parkinson’s disease (PD). She is now an NIHR BRC Clinical Senior Lecturer at the Translational and Clinical Research Institute, Newcastle University, deputy director of the Clinical Ageing Research Unit and honorary consultant in Older People’s Medicine at Newcastle upon Tyne Hospitals (NuTH) NHS Foundation Trust. Her research portfolio works toward targeting mobility impairment in PD by accurately measuring mobility, determining the mechanisms of impairment (with an emphasis on the contribution of acetylcholine) and pursuing potential interventions.  Her goal is to reduce adverse consequences associated with mobility loss, using PD as a model of multimorbidity, including falls, cognitive changes and muscle loss.